From omega-3s to probiotics, researchers have tested dozens of “natural” treatments for anxiety and depression. Only a few ...
Experts continue to debate whether the health status benefits are real and enough to justify doing the procedures for severe ...
One in six adults in England are taking antidepressants. That’s eight million people, yet remarkably even doctors don’t fully ...
As the practice has become more popular, it's important to note that 'deaths from cold-water immersion are not uncommon.' ...
Two newly approved medications expand options beyond lifestyle modifications for metabolic dysfunction-associated steatotic ...
Last year, the NHS prescribed paracetamol over 15 million times and the average person takes 70 a year. But while the ...
Jane Hirst and colleagues argue that novel modelling approaches using routinely collected data can be only as representative ...
A secondary analysis of TRAILBLAZER-ALZ 2 strengthens the case that reducing amyloid plaques underlies the clinical benefits ...
On October 8, 2025, the US FDA approved the immunotherapy cemiplimab-rwlc (Libtayo) for adjuvant treatment of adult patients ...
Praxis Precision surges on positive ulixacaltamide data for essential tremor, but tolerability limits impact. Explore PRAX's ...
A New York Times health reporter explains what makes a good study, and how she knows which papers merit an article.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback